Priority Date: 07.11.03 (US 20030517915P)

Pharmaceutically acceptable salts of quinolinone compounds and their medical use

  • Application ID: EP14165975
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicants

Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Novartis Pharma AG is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 232 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 07.11.2003 - Priority Date (US 20030517915P)
  • 06.08.2014 - Publication A1 (EP2762475)